The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here are three stocks where Wall Street’s enthusiasm may be misplaced and some other investments worth exploring instead.

RadNet (RDNT)

Consensus Price Target: $92.38 (65.4% implied return)

With over 350 imaging facilities across seven states and a growing artificial intelligence division, RadNet (NASDAQ: RDNT) operates a network of outpatient diagnostic imaging centers across the United States, offering services like MRI, CT scans, PET scans, mammography, and X-rays.

Why Are We Cautious About RDNT?

1. Revenue base of $2.04 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
2. Efficiency has decreased over the last five years as its adjusted operating margin fell by 3 percentage points
3. Poor free cash flow margin of 0.7% for the last five years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends

RadNet is trading at $55.87 per share, or 90.8x forward P/E. Dive into our free research report to see why there are better opportunities than RDNT.

ScanSource (SCSC)

Consensus Price Target: $51.67 (35.5% implied return)

Operating as a crucial link in the technology supply chain since 1992, ScanSource (NASDAQ: SCSC) is a hybrid distributor that connects hardware, software, and cloud services from technology suppliers to resellers and business customers.

Why Does SCSC Fall Short?

1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 8.6% annually over the last two years
2. Projected sales growth of 3% for the next 12 months suggests sluggish demand
3. Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital

At $38.14 per share, ScanSource trades at 8.8x forward P/E. To fully understand why you should be careful with SCSC, check out our full research report (it’s free).

Ladder Capital (LADR)

Consensus Price Target: $12.43 (25.4% implied return)

Founded during the 2008 financial crisis when traditional lenders retreated from commercial real estate, Ladder Capital (NYSE: LADR) is a real estate investment trust that originates commercial real estate loans, owns commercial properties, and invests in real estate securities.

Why Do We Think LADR Will Underperform?

1. Annual sales declines of 9.7% for the past two years show its products and services struggled to connect with the market during this cycle
2. Performance over the past two years shows each sale was less profitable as its earnings per share dropped by 20.4% annually, worse than its revenue
3. Flat tangible book value per share over the last five years suggest it must find different ways to enhance shareholder value during this cycle

Ladder Capital’s stock price of $9.91 implies a valuation ratio of 0.9x forward P/B. Check out our free in-depth research report to learn more about why LADR doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.